Leiter's Compounding Pharmacy

Amended 483 issued July 3, 2025 · San Jose, California

Inspection
Jun 23 – Jul 3, 2025
Observations
3
Pages
5
FEI number
3003434972

In short: On July 3, 2025, FDA issued a Amended 483 with 3 observations to Leiter's Compounding Pharmacy in San Jose, California (FEI 3003434972) after an inspection that ran Jun 23 – Jul 3, 2025. The investigators were Jolanna A. Norton and Matthew R. Clabeaux. Most observations concern production and quality system.

At a glance

Production and quality system account for 2 of 3 observations.

Production1
Quality system1
Facilities & equipment1

What FDA observed

Preview: the opening words of each observation
  1. 01

    Your firm failed to establish adequate written procedures for production and process controls designed to assure…

  2. 02

    Employees are not given training in the particular operations they perform as…

  3. 03

    Aseptic processing areas are deficient regarding the system…

The full amended 483

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full amended 483

This inspection in context

Questions about this amended 483

What did FDA find at Leiter's Compounding Pharmacy?

FDA listed 3 observations on this Form 483, mostly about production, quality system and facilities & equipment. The opening words of each observation are shown on this page.

Who inspected Leiter's Compounding Pharmacy?

Jolanna A. Norton and Matthew R. Clabeaux are named on this Amended 483, for the inspection of Jun 23 – Jul 3, 2025. Each investigator has a profile showing what they cite most.

When was Leiter's Compounding Pharmacy inspected by FDA?

The inspection ran Jun 23 – Jul 3, 2025, and the Amended 483 is dated July 3, 2025.

How do I get the full Amended 483 for Leiter's Compounding Pharmacy?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free